Sinulox RTU 40ml
DESCRIPTION
Sinulox RTU (Synulox RTU) is a combined antibacterial drug. Outwardly, Sinulox RTU is an oily suspension of light cream color.
COMPOSITION
Sinulox RTU in 1 ml contains 140 mg of amoxicillin (in the form of amoxicillin trihydrate) and 35 mg of clavulanic acid (in the form of potassium clavulanate) as active ingredients, and fractionated coconut oil as auxiliary substances.
PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group: combined antibacterial drug.
Amoxicillin active ingredient of Sinulox RTU is a semi-synthetic antibiotic of the penicillin group. Clavulanic acid inactivates the penicillase of penicillin-resistant microorganisms and thereby restores the sensitivity of bacteria to the bactericidal effect of amoxicillin.
The mechanism of the antibacterial action of amoxicillin is to suppress the functional activity of bacterial transpeptidase enzymes involved in binding the main component of the cell wall of microorganisms - peptidoglycan, which leads to the death of bacteria.
The combination of amoxicillin with clavulanic acid has a wide spectrum of bactericidal activity against the majority of gram-positive and gram-negative bacteria, including strains producing ОІ-lactamase: Staphylococcus, Streptococcus, Corynebacterium, Clostridium, Bacillus anthracis, Salmonstoceus anthracis, Actinomyces spppp. Bordetella bronchiseptica, Campylobacter spp., Klebsiella, Proteus spp., Pasteurella, Fusobacterium necrophorum, Bacteroides, Haemophilus spp., Moraxella spp., Actinobacillus pleuropneumoniae and Actinobacillus lignierisi.
Amoxicillin and clavulanic acid are rapidly absorbed from the injection site and reach their peak concentration 2 hours after drug administration. Excretion of the drug from the body occurs mainly in the urine. Sinulox R TU, according to the degree of exposure to the body, belongs to moderately hazardous compounds (hazard class 3 according to GOST 12.1.007).
PURPOSE
It is used in cattle, pigs, dogs and cats for respiratory diseases of bacterial etiology, postpartum infections, metritis, mastitis, skin and soft tissue infections.
DOSAGE AND APPLICATION
For the treatment of pregnant and lactating animals, the drug is prescribed in the indicated dosages, taking into account the waiting times for milk and meat.
Sinulox RTU is administered to animals at a dose of 8.75 mg of active ingredients per 1 kg of animal weight, which is equivalent to 1 ml of the drug per 20 kg of live weight. The drug is administered once a day, the course of treatment is from 3 to 5 days.
Before each use, the vial with Sinulox RTU is thoroughly shaken until a homogeneous suspension is obtained. For dogs and cats, the drug is administered intramuscularly or subcutaneously, for cattle and pigs, only intramuscularly. It is recommended to massage the injection site after the injection. Only dry syringes and needles are used to inject the drug. Sinulox R TU should not be administered intravenously or intratracheally.
SPECIAL INSTRUCTIONS
The peculiarities of the action of the drug during its first use and withdrawal have not been established.
Avoid gaps in the introduction of the next dose of the drug, as this can lead to a decrease in effectiveness. If you miss one dose, you must enter it as soon as possible. Further, the course of treatment must be resumed in the prescribed dosages and regimen.
Milk can be used for food purposes no earlier than 108 hours after the last use of the drug. Milk obtained before the expiration of the specified period can be used for feeding animals after heat treatment.
Slaughter of cattle for meat is allowed no earlier than after 42 days, pigs - no earlier than 31 days later. The meat of animals that were forcedly killed before the expiration of the specified period can be used for feeding fur-bearing animals.
CONTRAINDICATIONS
It is forbidden to apply Sinulox RTU to animals with hypersensitivity to ОІ-lactam antibiotics.
SIDE EFFECTS
When using the drug in accordance with this instruction, side effects and complications, as a rule, are not observed. In the event of allergic reactions, the use of the drug is discontinued and antihistamines and symptomatic treatment are prescribed.
SHELF LIFE AND STORAGE
The shelf life of the medicinal product, subject to storage conditions, is 2 years from the date of manufacture. The shelf life of the drug after the first puncture of the cork is 28 days under the specified storage conditions. It is forbidden to use the medicinal product after the expiration date.
Store the drug in a closed manufacturer's packaging in a place protected from direct sunlight, separately from food and feed, at a temperature of 2 В° C to 25 В° C.
PACKAGING
The drug is produced in glass bottles of the appropriate capacity of 40 ml, which are hermetically sealed with rubber stoppers, reinforced with aluminum caps. Each box contains instructions for using the medicinal product in Russian.
Specifications
Bonus points
0
KolVUP
12
Manufacturer
Zoetis
Temperature regime
from +2 to +25
Teaser
combined antibacterial drug